Guanylate cyclase C is the receptor for the bacterial heat-stable enterotox
ins and guanylin family of peptides, and mediates its action by elevating i
ntracellular cGMP levels. Potentiation of ligand-stimulated activity of gua
nylate cyclase C in human colonic T84 cells is observed following activatio
n of protein kinase C as a result of direct phosphorylation of guanylate cy
clase C. Here, we show that prolonged exposure of cells to phorbol esters r
esults in a decrease in guanylate cyclase C content in il P-phorbol 12-myri
state 13-acetate-treated cells, as a consequence of a decrease in guanylate
cyclase C mRNA levels. The reduction in guanylate cyclase C mRNA was inhib
ited when cells were treated with 4 beta -phorbol 12-myristate 13-acetate (
PMA) in the presence of staurosporine, indicating that a primary phosphoryl
ation event by protein kinase C triggered the reduction in RNA levels. The
reduction in guanylate cyclase C mRNA levels was not due to alterations in
the half-life of guanylate cyclase C mRNA, but regulation occurred at the l
evel of transcription of guanylate cyclase C mRNA. Expression in T84 cells
of a guanylate cyclase C promoter-luciferase reporter plasmid, containing 1
973 bp of promoter sequence of the guanylate cyclase C gene, indicated that
luciferase activity was reduced markedly on PMA treatment of cells, and th
e protein kinase C-responsive element was present in a 129-bp region of the
promoter, containing a HNF4 binding element. Electrophoretic mobility shif
t assays using an oligonucleotide corresponding to the HNF4 binding site, i
ndicated a decrease in binding of the factor to its cognate sequence in nuc
lear extracts prepared from PMA-treated cells. We therefore show for the fi
rst time that regulation of guanylate cyclase C activity can be controlled
at the transcriptional level by cross-talk with signaling pathways that mod
ulate protein kinase C activity. We also suggest a novel regulation of the
HNF4 transcription factor by protein kinase C.